Cargando…

Neutralizing Antibodies after Infection with Dengue 1 Virus

Severity of disease is markedly increased when infection with dengue virus type 2 (DENV-2) follows infection with DENV-1. Studies have shown that heterologous neutralizing antibody titers are inversely correlated with severity of a second infection. If this mechanism controlled disease severity in C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guzman, Maria G., Alvarez, Mayling, Rodriguez-Roche, Rosmari, Bernardo, Lídice, Montes, Tibaire, Vazquez, Susana, Morier, Luis, Alvarez, Angel, Gould, Ernest A, Kourí, Gustavo, Halstead, Scott B
Formato:	Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2007
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2725871/ https://www.ncbi.nlm.nih.gov/pubmed/17479892 http://dx.doi.org/10.3201/eid1302.060539

Ejemplares similares

Dengue Virus Type 3, Cuba, 2000–2002
por: Rodriguez-Roche, Rosmari, et al.
Publicado: (2005)

Dengue 3 Epidemic, Havana, 2001
por: Peláez, Otto, et al.
Publicado: (2004)

Understanding the Dengue Viruses and Progress towards Their Control
por: Rodriguez-Roche, Rosmari, et al.
Publicado: (2013)

Biological and Molecular Properties of Dengue 2 Strains Isolated during the DHF/DSS Cuban Epidemic, 1981
por: González, Lester, et al.
Publicado: (2007)

Increasing Clinical Severity during a Dengue Virus Type 3 Cuban Epidemic: Deep Sequencing of Evolving Viral Populations
por: Rodriguez-Roche, Rosmari, et al.
Publicado: (2016)

Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody
por: Halstead, SB, et al.
Publicado: (1977)

The Complexity of Antibody-Dependent Enhancement of Dengue Virus Infection
por: Guzman, Maria G., et al.
Publicado: (2010)

Population structure of the dengue viruses, Aragua, Venezuela, 2006–2007. Insights into dengue evolution under hyperendemic transmission
por: Rodriguez-Roche, Rosmari, et al.
Publicado: (2012)

Multi-Tissue Transcriptomic-Informed In Silico Investigation of Drugs for the Treatment of Dengue Fever Disease
por: Sierra, Beatriz, et al.
Publicado: (2021)

Biologic Evidence Required for Zika Disease Enhancement by Dengue Antibodies
por: Halstead, Scott B.
Publicado: (2017)

Evaluation of Commercially Available Diagnostic Tests for the Detection of Dengue Virus NS1 Antigen and Anti-Dengue Virus IgM Antibody
por: Hunsperger, Elizabeth A., et al.
Publicado: (2014)

Broad dengue neutralization in mosquitoes expressing an engineered antibody
por: Buchman, Anna, et al.
Publicado: (2020)

Antibody affinity versus dengue morphology influences neutralization
por: Fibriansah, Guntur, et al.
Publicado: (2021)

Correlation between Dengue-Specific Neutralizing Antibodies and Serum Avidity in Primary and Secondary Dengue Virus 3 Natural Infections in Humans
por: Puschnik, Andreas, et al.
Publicado: (2013)

Neutralizing Dengue Antibody in Pregnant Thai Women and Cord Blood
por: Khamim, Kriangsak, et al.
Publicado: (2015)

Correction: Broad dengue neutralization in mosquitoes expressing an engineered antibody
por: Buchman, Anna, et al.
Publicado: (2020)

Dengue Reporter Virus Particles for Measuring Neutralizing Antibodies against Each of the Four Dengue Serotypes
por: Mattia, Kimberly, et al.
Publicado: (2011)

Controversies in dengue pathogenesis
por: Halstead, Scott B
Publicado: (2012)

Recent advances in understanding dengue
por: Halstead, Scott
Publicado: (2019)

Reemergence of dengue in Cuba: a 1997 epidemic in Santiago de Cuba.
por: Kourí, G, et al.
Publicado: (1998)

More Dengue, More Questions
por: Halstead, Scott B.
Publicado: (2005)

Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered.
por: Halstead, S. B., et al.
Publicado: (1970)

Potent Zika and dengue cross-neutralizing antibodies induced by Zika vaccination in a dengue-experienced donor
por: Dussupt, Vincent, et al.
Publicado: (2020)

Dengue and hemorrhagic fevers of Southeast Asia.
por: Halstead, S. B.
Publicado: (1965)

Natural Strain Variation and Antibody Neutralization of Dengue Serotype 3 Viruses
por: Wahala, Wahala M. P. B., et al.
Publicado: (2010)

Augmented Zika and Dengue Neutralizing Antibodies Are Associated With Guillain-Barré Syndrome
por: Lynch, Rebecca M, et al.
Publicado: (2019)

OSBPL10, RXRA and lipid metabolism confer African-ancestry protection against dengue haemorrhagic fever in admixed Cubans
por: Sierra, Beatriz, et al.
Publicado: (2017)

The tetravalent formulation of domain III-capsid proteins recalls memory B- and T-cell responses induced in monkeys by an experimental dengue virus infection
por: Gil, Lázaro, et al.
Publicado: (2017)

Optimization and Validation of a Plaque Reduction Neutralization Test for the Detection of Neutralizing Antibodies to Four Serotypes of Dengue Virus Used in Support of Dengue Vaccine Development
por: Timiryasova, Tatyana M., et al.
Publicado: (2013)

Analysis of Cross-Reactive Antibodies Recognizing the Fusion Loop of Envelope Protein and Correlation with Neutralizing Antibody Titers in Nicaraguan Dengue Cases
por: Lai, Chih-Yun, et al.
Publicado: (2013)

Dengue virus neutralizing antibody: a review of targets, cross-reactivity, and antibody-dependent enhancement
por: Sarker, Animesh, et al.
Publicado: (2023)

Autophagy-associated dengue vesicles promote viral transmission avoiding antibody neutralization
por: Wu, Yan-Wei, et al.
Publicado: (2016)

Reappearance of Chikungunya, Formerly Called Dengue, in the Americas
por: Halstead, Scott B.
Publicado: (2015)

Pathogenesis of Dengue: Dawn of a New Era
por: Halstead, Scott B.
Publicado: (2015)

Pediatric Measles Vaccine Expressing a Dengue Antigen Induces Durable Serotype-specific Neutralizing Antibodies to Dengue Virus
por: Brandler, Samantha, et al.
Publicado: (2007)

Induction of Neutralizing Antibodies against Four Serotypes of Dengue Viruses by MixBiEDIII, a Tetravalent Dengue Vaccine
por: Zhao, Hui, et al.
Publicado: (2014)

Cross-Reaction, Enhancement, and Neutralization Activity of Dengue Virus Antibodies against Zika Virus: A Study in the Mexican Population
por: Montecillo-Aguado, Mayra R., et al.
Publicado: (2019)

Observations related to the pathogenesis of dengue hemorrhagic fever. II. Antigenic and biologic properties of dengue viruses and their association with disease response in the host.
por: Halstead, S. B., et al.
Publicado: (1970)

Neutralization of antibody-enhanced dengue infection by VIS513, a pan serotype reactive monoclonal antibody targeting domain III of the dengue E protein
por: Budigi, Yadunanda, et al.
Publicado: (2018)

Assessing the prognosis of dengue-infected patients
por: Halstead, Scott B, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_sm5k5gqq1ndbor1cc7ls3ikb8a